About Patrona Medical
Patrona Medical, Inc. is a medical device company focused on the field of Urology. Most specifically the prevention of Cather Associated Urinary Tract Infections, (CAUTI). We have developed a patent pending technology that utilizes a color matrix process to determine a patient’s current colony count, allowing for intervention long before bacteria reach infectious levels.
Catheter Associated Urinary Tract Infections (CAUTI) account for 40% of all Hospital Acquired Infections (HAI). CAUTI’s are responsible for 680,000 deaths globally and more than 13,00 American deaths annually. The Affordable Care Act mandates a penalty for U.S. healthcare providers whom have high infections rates, and cost U.S. health care industry 490 – 520 million in lost reimbursements. Globally these deadly and costly infections total more than 4.2 – 4.8 Billion in lost revenue and direct and indirect cost.
Our vision is to provide medical devices that improve the quality of care for patients through increased detection, accelerated efficiency, and automated communication.
What is next? Our technology creates an automated interface between monitoring systems and patient care providers. These advancements detect potential complications, reduce associated costs, support our care providers, and increase the overall quality of care.